Trends in willingness to receive COVID-19 vaccines among healthcare workers in India: Findings from repeated cross-sectional national surveys.
domestic vaccine
hesitancy
intention
trust
vaccine acceptance
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
07
2022
accepted:
14
09
2022
entrez:
20
10
2022
pubmed:
21
10
2022
medline:
22
10
2022
Statut:
epublish
Résumé
COVID-19 vaccination of the healthcare workers (HCWs) is a key priority in the fight against the SARS-CoV-2 pandemic. India launched its COVID-19 vaccination program in January 2021. We aimed to understand the trends in willingness to receive COVID-19 vaccines and its associated factors among HCWs in India. Using a repeated cross-sectional survey design, we collected information from HCWs in three critical time points: before ( Of the study participants, 43.7, 60.2, and 73.2% were willing to receive COVID-19 vaccines during the first, second and third rounds of surveys, respectively. In multivariable logistic regression analysis, participants who trusted the health care system were more likely to report willingness to receive a COVID-19 vaccine; medical trust emerged as a significant factor in all the three rounds of surveys (First survey-aOR: 2.24, 95% CI: 1.67-2.99; Second survey-aOR: 3.38, 95% CI: 2.64-4.33; Third survey-aOR: 2.54, 95% CI: 1.65-3.91). Having confidence in domestic vaccines (Second survey-aOR: 2.21, 95% CI: 1.61-3.02; Third survey-aOR: 2.05, 95% CI: 1.24-3.37); and high perceived risk of contracting COVID-19 (Second survey-aOR: 1.48, 95% CI: 1.13-1.93; Third survey-aOR: 2.02, 95% CI: 1.31-3.13) were found to be associated with willingness to receive vaccines. Among socio-demographic characteristics, being married (aOR: 1.71, 95% CI: 1.08-2.71) and having high socio-economic status (aOR: 3.01, 95% CI: 1.65-5.51) emerged as significant factors associated with willingness to receive COVID-19 vaccines in the third round of the surveys. Willingness to receive COVID-19 vaccine increased with time, as the severity of the pandemic increased. To increase COVID-19 acceptance and coverage among HCWs, it is important to instill confidence in domestic vaccines and assist in accurate assessment of risk toward contracting COVID-19 infection.
Sections du résumé
Background
COVID-19 vaccination of the healthcare workers (HCWs) is a key priority in the fight against the SARS-CoV-2 pandemic. India launched its COVID-19 vaccination program in January 2021. We aimed to understand the trends in willingness to receive COVID-19 vaccines and its associated factors among HCWs in India.
Methods
Using a repeated cross-sectional survey design, we collected information from HCWs in three critical time points: before (
Findings
Of the study participants, 43.7, 60.2, and 73.2% were willing to receive COVID-19 vaccines during the first, second and third rounds of surveys, respectively. In multivariable logistic regression analysis, participants who trusted the health care system were more likely to report willingness to receive a COVID-19 vaccine; medical trust emerged as a significant factor in all the three rounds of surveys (First survey-aOR: 2.24, 95% CI: 1.67-2.99; Second survey-aOR: 3.38, 95% CI: 2.64-4.33; Third survey-aOR: 2.54, 95% CI: 1.65-3.91). Having confidence in domestic vaccines (Second survey-aOR: 2.21, 95% CI: 1.61-3.02; Third survey-aOR: 2.05, 95% CI: 1.24-3.37); and high perceived risk of contracting COVID-19 (Second survey-aOR: 1.48, 95% CI: 1.13-1.93; Third survey-aOR: 2.02, 95% CI: 1.31-3.13) were found to be associated with willingness to receive vaccines. Among socio-demographic characteristics, being married (aOR: 1.71, 95% CI: 1.08-2.71) and having high socio-economic status (aOR: 3.01, 95% CI: 1.65-5.51) emerged as significant factors associated with willingness to receive COVID-19 vaccines in the third round of the surveys.
Interpretation
Willingness to receive COVID-19 vaccine increased with time, as the severity of the pandemic increased. To increase COVID-19 acceptance and coverage among HCWs, it is important to instill confidence in domestic vaccines and assist in accurate assessment of risk toward contracting COVID-19 infection.
Identifiants
pubmed: 36262227
doi: 10.3389/fpubh.2022.994206
pmc: PMC9574381
doi:
Substances chimiques
COVID-19 Vaccines
0
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
994206Informations de copyright
Copyright © 2022 Padhi, Chakrapani, Gupta, Sharma, Patro, Kar, Singh, Pala, Sankhe, Modi, Bali, Rustagi, Jain, Vij, Satapathy, Goel, Rajagopal, Kiran and Aggarwal.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Epidemiol Infect. 2021 May 20;149:e132
pubmed: 34011421
MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924
pubmed: 33332292
Nat Med. 2021 Jun;27(6):929
pubmed: 34031608
Vaccine. 2011 Feb 11;29(8):1605-10
pubmed: 21211593
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
MMWR Morb Mortal Wkly Rep. 2010 Apr 2;59(12):363-8
pubmed: 20360670
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
J Public Health (Oxf). 2021 Sep 22;43(3):445-449
pubmed: 33367857
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Front Public Health. 2021 Dec 15;9:735902
pubmed: 34976911
Am J Public Health. 2012 Apr;102(4):672-9
pubmed: 22397349
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1653-1656
pubmed: 33382675
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
PLOS Glob Public Health. 2021 Oct 13;1(10):e0000020
pubmed: 36962089
Psychol Med. 2022 Oct;52(14):3127-3141
pubmed: 33305716
BMC Public Health. 2021 Jun 12;21(1):1129
pubmed: 34118897